ACTIVE

Minerva:Belgisch tijdschrift voor promotie van Evidence Based Medicine in de eerste lijn

Financial year 2021 · Closed on 31/12/2021

Net result2,7 k €-80,0 %over 1 year

Gross margin108,5 k €-8,9 %over 1 year

Equity135,5 k €+2,0 %over 1 year

Identity

Source · BCE/KBO

Minerva:Belgisch tijdschrift voor promotie van Evidence Based Medicine in de eerste lijn is a Non-profit organization incorporated in 2004. Its main activity is: Manufacture of rubber products. Its registered office is in Gent.

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0865.041.446
Incorporation: 30/04/2004
Legal form: Non-profit organization
Registered office: Corneel Heymanslaan 10
9000 Gent · FlandreSee on map
Latest accounts: 31/12/2021

Activities (NACE)

22130Manufacture of rubber products· main 58130Publishing of newspapers 58140Publishing of journals and periodicals

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 14 filings

Trend over 12 financial years

	2021		2020		2019		2018		2017
Income statement
Gross margin	108,5 k €	-8.9%	119,1 k €	-4.1%	124,2 k €	-10.7%	139,2 k €	-7.9%	151,2 k €
EBITDA	2,9 k €	-78.6%	13,4 k €	-35.3%	20,7 k €	+103%	10,2 k €	-45.7%	18,8 k €
Operating result	2,7 k €	-79.7%	13,4 k €	-35.3%	20,7 k €	+103%	10,2 k €	-40.0%	17 k €
Net result	2,7 k €	-80.0%	13,3 k €		–		–		–
Balance sheet
Equity	135,5 k €	+2.0%	132,9 k €	+11.2%	119,5 k €	+20.9%	98,8 k €	+11.4%	88,7 k €
Total assets	171,8 k €	+11.7%	153,8 k €	+9.4%	140,6 k €	+14.5%	122,8 k €	+3.9%	118,2 k €
Cash	119,4 k €	-9.7%	132,3 k €	+13.0%	117,1 k €	+15.9%	101 k €	+20.3%	84 k €
Debts	19,4 k €	-7.4%	20,9 k €	-0.5%	21 k €	-12.2%	24 k €	-17.7%	29,1 k €
Other
Workforce	–		2,0 ETP	+5.3%	1,9 ETP	-17.4%	2,3 ETP	-4.2%	2,4 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 100 k€ and 250 k€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2021

4 active · 27 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Annier De Sutter	Mandate
Bert Aertgeerts	Mandate
Roy Remmen	MandateChairman of the board of directorsended
Therese Van Durme	MandateDirectorended

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
An Mevr. De Sutter	Mandate30/06/2015 → 30/06/2019
Bert Dhr. Aertgeerts	Mandate30/06/2015 → 30/06/2019
Didier Dhr. Thillaye du Boullay	Mandate30/06/2015 → 30/06/2019
Jan Dhr. De Maeseneer	Director30/06/2015 → 30/06/2019

Other companies at this address

Corneel Heymanslaan 10 9000 Gent

Company	CBE no.
B-Audio● Active	1024.100.660
Belgian Association of Ambulatory Surgery● Active	0458.243.539
Belgian Medical Students’ Association● Active	0536.703.374
Belgian Society for Trauma● Active	1021.878.073
Belgian Society for Virology● Active	0724.541.894
Belgische Academie voor Pediatrische Tandheelkunde● Active	0462.178.076
Belgische Vereniging voor Inwendige Geneeskunde - Société belge de Médecine Interne - Belgian Society of Internal Medicine● Active	0460.965.081
Care for adolescents and young adults● Active	0693.976.305
Centrum voor Ontwikkelingsstoornissen-Gent● Active	0439.041.794
Collaboratief Zorgplatform Vlaanderen● Active	0515.948.443
CRIG-fonds● Active	0715.910.379
Dappere B-engeltjes● Active	0637.973.948
DENTALUMNI● Active	0563.934.838
Een Hart voor de Ziekenhuisschool Stad Gent● Active	0774.958.932
Epilepsie Liga● Active	0423.599.493
ESDP European Society for Developmental Perinatal & Paediatric Pharmacology vereniging zonder winstoogmerk● Active	0518.986.325
Forum Assistenten Klinische Biologie● Active	0777.449.951
KINDERDAGVERBLIJF UZ GENT DE KNUFFELBOOM● Active	0478.310.859
Liga voor obsessieve-compulsieve stoornissen● Active	0798.541.117
Neuro Interesse Groep● Active	0445.585.435

Full financial information

Source · NBB

	2021	2020	2019	2018	2017	2016
Type of account	Micro model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2021	01/01/2020	01/01/2019	01/01/2018	01/01/2017	01/01/2016
Closing of the financial year	31/12/2021	31/12/2020	31/12/2019	31/12/2018	31/12/2017	31/12/2016
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	19/12/2022	28/10/2021	01/09/2020	11/09/2019	07/08/2018	25/07/2017
General meeting	18/10/2022	14/10/2021	09/07/2020	13/06/2019	21/06/2018	22/06/2017
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 14 filings

Model	Closing	General meeting	Filed	Language	Document
Micro model	31/12/2021	18/10/2022	19/12/2022	Dutch	PDF
Abridged model	31/12/2020	14/10/2021	28/10/2021	Dutch	PDF
Abridged model	31/12/2019	09/07/2020	01/09/2020	Dutch	PDF
Abridged model	31/12/2018	13/06/2019	11/09/2019	Dutch	PDF
Abridged model	31/12/2017	21/06/2018	07/08/2018	Dutch	PDF
Abridged model	31/12/2016	22/06/2017	25/07/2017	Dutch	PDF
Abridged model	31/12/2015	13/09/2016	27/09/2016	Dutch	PDF
Abridged model	31/12/2014	21/04/2015	03/09/2015	Dutch	PDF
Abridged model	31/12/2013	12/06/2014	26/08/2014	Dutch	PDF
Abridged model	31/12/2012	28/05/2013	19/11/2013	Dutch	PDF
Abridged model	31/12/2011	17/05/2012	12/06/2012	Dutch	PDF
Abridged model	31/12/2010	18/05/2011	28/06/2011	Dutch	PDF
Abridged model	31/12/2009	18/05/2010	30/06/2010	Dutch	PDF
Abridged model	31/12/2008	10/03/2009	06/04/2009	Dutch	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 100 k€ and 250 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2021

4 active · 27 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Annier De Sutter	Mandate
Bert Aertgeerts	Mandate
Roy Remmen	MandateChairman of the board of directorsended
Therese Van Durme	MandateDirectorended

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
An Mevr. De Sutter	Mandate30/06/2015 → 30/06/2019
Bert Dhr. Aertgeerts	Mandate30/06/2015 → 30/06/2019
Didier Dhr. Thillaye du Boullay	Mandate30/06/2015 → 30/06/2019
Jan Dhr. De Maeseneer	Director30/06/2015 → 30/06/2019

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates07/03/2023
MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
PDF
Mandates09/02/2022
ONTSLAGEN - BENOEMINGEN
PDF
Mandates29/12/2016
ONTSLAGEN - BENOEMINGEN
PDF
Mandates05/08/2010
ONTSLAGEN - BENOEMINGEN
PDF
Mandates14/03/2005
ONTSLAGEN - BENOEMINGEN
PDF
Other11/05/2004
RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings12 filings

Mandates

Didier Dhr. Thillaye du Boullay

Roy Dhr. Remmen

Jan Dhr. De Maeseneer

Luc Dhr. Ailliet

Bert Dhr. Aertgeerts

An Mevr. De Sutter

D Pestiaux

J De Maeseneer

E Vermeire

M Prof Roland

J Prof. De Maeseneer

B Prof Aertgeerts

and 12 more mandates

20042005200620072008200920102011201220132014201520162017201820192020202120222023202420252026

Minerva:Belgisch tijdschrift voor promotie van Evidence Based Medicine in de eerste lijn

Chairman of the board of directors

Director

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Corneel Heymanslaan 10, 9000 GentCurrent		CBE
De Pintelaan 185 bte 1K3, 9000 Gent	accounts 2021	Accounts 2021 · 2022-20539457

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
Minerva:Belgisch tijdschrift voor promotie van Evidence Based Medicine in de eerste lijnCurrent	accounts 2009 → 2021	Accounts 2021 · 2022-20539457

Events

2021
Annual accounts 20212,7 k €↓
2020
Annual accounts 202013,3 k €↑
2019
Annual accounts 2019
2018
Annual accounts 2018
2017
Annual accounts 2017
2016
Annual accounts 2016
2015
Annual accounts 2015
2014
Annual accounts 2014-5,8 k €↑
2013
Annual accounts 2013-35,4 k €↓
2012
Annual accounts 2012-32,5 k €↓
2011
Annual accounts 201126,9 k €↑
2009
Annual accounts 2009-9,2 k €
30/04/2004
IncorporationNon-profit organization

Minerva:Belgisch tijdschrift voor promotie van Evidence Based Medicine in de eerste lijn

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events